JP2010533735A5 - - Google Patents

Download PDF

Info

Publication number
JP2010533735A5
JP2010533735A5 JP2010517190A JP2010517190A JP2010533735A5 JP 2010533735 A5 JP2010533735 A5 JP 2010533735A5 JP 2010517190 A JP2010517190 A JP 2010517190A JP 2010517190 A JP2010517190 A JP 2010517190A JP 2010533735 A5 JP2010533735 A5 JP 2010533735A5
Authority
JP
Japan
Prior art keywords
composition
peptide
seq
fragment
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010517190A
Other languages
English (en)
Japanese (ja)
Other versions
JP5438676B2 (ja
JP2010533735A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/070496 external-priority patent/WO2009012460A1/en
Publication of JP2010533735A publication Critical patent/JP2010533735A/ja
Publication of JP2010533735A5 publication Critical patent/JP2010533735A5/ja
Application granted granted Critical
Publication of JP5438676B2 publication Critical patent/JP5438676B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010517190A 2007-07-19 2008-07-18 癌ワクチンとしてのサバイビンペプチド Active JP5438676B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96120607P 2007-07-19 2007-07-19
US60/961,206 2007-07-19
PCT/US2008/070496 WO2009012460A1 (en) 2007-07-19 2008-07-18 Survivin peptides as cancer vaccines

Publications (3)

Publication Number Publication Date
JP2010533735A JP2010533735A (ja) 2010-10-28
JP2010533735A5 true JP2010533735A5 (https=) 2011-07-21
JP5438676B2 JP5438676B2 (ja) 2014-03-12

Family

ID=40260098

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010517190A Active JP5438676B2 (ja) 2007-07-19 2008-07-18 癌ワクチンとしてのサバイビンペプチド

Country Status (8)

Country Link
US (1) US7943138B2 (https=)
EP (1) EP2178548B1 (https=)
JP (1) JP5438676B2 (https=)
KR (1) KR101585042B1 (https=)
CN (1) CN101754768B (https=)
CA (1) CA2694011C (https=)
ES (1) ES2529193T3 (https=)
WO (1) WO2009012460A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7612162B2 (en) * 2004-09-21 2009-11-03 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response
WO2011011688A2 (en) * 2009-07-24 2011-01-27 Rhode Island Hospital DENDRITIC CELL VACCINES FOR ASPARAGINYL- β - HYDROXYLASE EXPRESSING TUMORS
CA2809362C (en) 2010-08-24 2020-03-10 University Of Pittsburgh - Of The Commonwealth System Of Higher Educatn Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
CA3183703A1 (en) 2012-05-16 2013-11-21 Stemline Therapeutics, Inc. Cancer stem cell targeted cancer vaccines
DK3122375T3 (da) 2014-03-28 2021-05-25 Univ Washington Through Its Center For Commercialization Vacciner mod bryst- og ovariecancer
AU2016306408B2 (en) 2015-08-10 2021-02-11 Toray Industries, Inc. Immune inducer
KR102773176B1 (ko) * 2015-09-04 2025-02-27 헬스 리서치 인코포레이티드 암 치료용 안티-서비빈 항체
GB201604755D0 (en) * 2016-03-21 2016-05-04 Vaxeal Res Sas Immunogenic compositions
WO2025159614A1 (ko) * 2024-01-23 2025-07-31 한양대학교 산학협력단 데옥시콜산과 연결된 암항원 펩타이드를 포함하는 나노구조체 및 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
US7892559B2 (en) * 2002-01-30 2011-02-22 Survac Aps Survivin-derived peptides and use thereof
WO2005115447A2 (en) * 2004-05-25 2005-12-08 The Trustees Of The University Of Pennsylvania Human anti-cancer immunotherapy
US20070104689A1 (en) * 2005-09-27 2007-05-10 Merck Patent Gmbh Compositions and methods for treating tumors presenting survivin antigens

Similar Documents

Publication Publication Date Title
JP2010533735A5 (https=)
RU2012153218A (ru) Пептиды, проникающие в клетки, и их применения
NZ710626A (en) Pcsk9 vaccine
EP2583976A3 (en) Peptide vaccines with SEQ ID NO: 210, 196, 202, 213, 214, 214 or 223 for cancers expressing tumor-associated antigens
WO2008140621A3 (en) Transgenic oncolytic viruses and uses thereof
NZ608972A (en) Engineered nucleic acids and methods of use thereof
UA110599C2 (uk) Пептид для імунотерапії пухлин, включаючи нейрональні пухлини та пухлини мозку
NZ601818A (en) Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of gastric cancer and other cancers
UA110806C2 (uk) Мікобактеріальна антигенна композиція
RU2010125605A (ru) Антитело против глипикана-3 с улучшенными кинетическими показателями в плазме
RU2011138160A (ru) Пептиды foxmi и вакцины, содержащие их
CN107760716A (zh) 草鱼呼肠孤病毒s11基因真核表达重组质粒的制备方法及其作为核酸疫苗的应用
CN103804482B (zh) 一种抗菌肽及其应用
NZ609916A (en) Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
CN111513077A (zh) 一种RNAi纳米制剂及其制备方法和在TMV防治中的应用
RU2017126566A (ru) ВСТРЕЧАЮЩИЕСЯ В ПРИРОДЕ миРНК ДЛЯ КОНТРОЛИРОВАНИЯ ЭКСПРЕССИИ ГЕНОВ И ИХ ПРИМЕНЕНИЕ
JP2014527801A5 (https=)
RU2013126628A (ru) Иммуномодулирующие способы и системы для лечения и/или предотвращения аневризм
RU2012147590A (ru) Пептиды cdca5 и содержащие их вакцины
JP2015524788A5 (https=)
RU2013111675A (ru) Рекомбинантный fc-гибридный белок пятого домена фибронектина типа iii dcc
JP2015529629A5 (https=)
HRP20240359T1 (hr) Peptidi iz piwil1
JP2015524652A5 (https=)
CN103589693A (zh) 一种表达ibdv vp2和法氏囊素三肽嵌合蛋白重组火鸡疱疹病毒